Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) vs Tencent Music Entertainment Group - ADR (TME) Price & Performance

Bio-Rad Laboratories, Inc. Class A Common StockTrade
Tencent Music Entertainment Group - ADRTrade

Price performance (Past 24H)

Key statistics

Bio-Rad Laboratories, Inc. Class A Common Stock vs Tencent Music Entertainment Group - ADR — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.04B), while Tencent Music Entertainment Group - ADR trades at $8.85 (market cap $14.62B). The key difference: Tencent Music Entertainment Group - ADR is the larger of the two by market cap, and Tencent Music Entertainment Group - ADR pays a 2.73% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.

BIOTME
Market Cap
$8.04B$14.62B
Sector
HealthMedia
52-Week High
$339.75$26.36
52-Week Low
$241.71$8.16
Enterprise Value
$7.85B$11.39B
Dividend Yield
2.73%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bio-Rad Laboratories, Inc. Class A Common Stock

BIO trades at $297.58, up 0.5% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $305. The stock shows strong profitability with a 51.87% gross margin and positive net income of $760M in 2025, though recent quarters have seen EPS misses. Cash flow from operations remains robust at $532M, supporting financial stability.

Outlook is cautiously optimistic with analyst support, but risks include earnings volatility and high P/E valuation. The company's return to profitability and solid balance sheet provide a foundation for growth, though investors should monitor execution against future earnings expectations and competitive pressures in the biotech sector.

Tencent Music Entertainment Group - ADR

TME trades at $8.83, down 0.56% today, with neutral technical signals and mixed earnings performance. The company reported strong revenue growth to $32.90B in 2025 and maintains solid profitability with a 26.48% net margin. Recent news highlights strategic moves including the Ximalaya acquisition and SEND audio technology development. Analyst consensus is divided with a $14.00 price target suggesting significant upside from current levels.

The investment outlook balances attractive valuation metrics against competitive pressures. With a P/E of 10.57 and strong cash flow generation, TME offers value potential, though recent earnings misses and intensifying competition present near-term challenges. The stock appears positioned for recovery if execution improves and premium content initiatives gain traction.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Read more on BIO

About Tencent Music Entertainment Group - ADR

TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.

Read more on TME